Quantcast
Radio Facts
Home » BLOG » Howard University Salutes Black History Legend: Dr. Roland B. Scott, Pioneering Sickle Cell Researcher
HBCU

Howard University Salutes Black History Legend: Dr. Roland B. Scott, Pioneering Sickle Cell Researcher

Dr. Roland B. Scott was a groundbreaking medical researcher in an era of intense discrimination .

WASHINGTON, D. C. (February 22, 2019) Each year Black History Month attention to the role that leading African Americans have played in shaping American life. Howard University proudly puts the spotlight on the contributions of Dr. Roland B. Scott, whose tireless research and advocacy in sickle cell disease deserve to be remembered.

At the time of his death, on Dec 10, 2002, Dr. Scott was recognized as the father of research into sickle cell disease. He was a groundbreaking researcher in an era of intense discrimination against Blacks. He was the primary for the National Sickle Cell Control Act of 1972, and founding director of the Howard University for Sickle Cell Disease, the first center in the nation devoted to the disease. Dr. Scott was the first chair of pediatrics in the Howard University College of Medicine and one of the first two African-American fellows of the American Academy of Pediatrics.

“Dr. Scott is the person who put sickle cell disease on the map,” says Dr. Oswaldo Castro, who was recruited to Howard University by Dr. Scott and later became director of the Center for Sickle Cell Disease. “He put sickle cell disease at the forefront of government health policies.”

Scott was born on April 18, 1909 in Houston, and grew up there and in Kansas City, Missouri. He opted for Howard University for his undergraduate studies based on his mother’s desire for him to be educated in a comfortable social environment. He studied chemistry and went on to earn a medical degree from the Howard University College of Medicine in 1934.

As a medical student, Scott was encouraged to study diseases that affected children and later he decided to focus on pediatric medicine. But Dr. Scott had difficulty obtaining a residency in pediatrics because, at the time, hospitals were taking only whites, Dr. Castro observed.

“Dr. Scott grew up during a time of discrimination, at a time when it was very difficult to get ahead,” Dr. Castro says. “Most people would have been frustrated by the difficulty, but he was able to triumph.”

In 1939, Dr. Scott returned to Howard University to an as assistant professor of pediatrics. He spent the rest of his career there. After seeing many children with symptoms of sickle cell disease admitted to Howard University Hospital, Dr. Scott began to focus on study of disease.

Over the next few decades, Dr. Scott and -workers at Howard University published hundreds of articles on sickle cell disease as well as on treatment methods. In 1948, Dr. Scott authored a pioneering scientific study on the incidence of red cell sickling in newborn infants. Outside of sickle cell disease, Dr. Scott was also the first to report growth and norms for healthy African-American children, which became the basis of nationwide standards.

Among his biggest challenges was persuading the government to provide funding for research. Dr. Scott lobbied the U.S. Congress tirelessly and testified on a number of occasions to get the legislation passed. His years of advocacy culminated in the passage of the Sickle Cell Anemia Control Act of 1971, which provided nationwide federal funding into the disease.

In 1972, Dr. Scott established Howard University’s Center for Sickle Cell Disease. In to implementing comprehensive patient and research into the disease, Dr. Scott organized yearly national conferences on blood diseases. His legacy continues now through lectures such that bear his name at Howard University.

The Howard University Center for Sickle Cell Disease remains a key U.S. institute for the study of new sickle cell drugs. The center has a history of treating a high volume of patients and, as a result, has participated in every major clinical trial that has led to FDA-approved medications for sickle cell disease.

Photo : Howard University Moorland-Spingarn Research Center.

For media inquiries, please contact Sholnn Freeman, [email protected]

About Howard University

Founded in 1867, Howard University is a private, research university that is comprised of 13 schools and colleges. Students pursue studies in more than 120 areas leading to undergraduate, graduate and professional degrees. The University operates with a commitment to Excellence in Truth and Service and has produced four Rhodes Scholars, 11 Truman Scholars, two Marshall Scholars, one Schwarzman Scholar, over 70 Fulbright Scholars and 22 Pickering Fellows. Howard also produces more on-campus African-American Ph.D. recipients than any other university in the United States.  For more information on Howard University visit www.howard.edu.


Related posts

Howard University Appoints Andrea D. Jackson as Dean of the College of Dentistry

sholnn.freeman

Howard University College of Pharmacy Opens Registration for Major Opioid Symposium Sept. 6

sholnn.freeman

NPR Releases ‘Wade in the Water’ 26-Part Series on 25th Anniversary, Produced by Howard Faculty and Alumni

Jimmy August

Community Explores New Efforts to Battle Sickle Cell Disease at Howard University Symposium

Jimmy August

Howard University Physicians to Men: ‘Take control of your health’

Jimmy August

Howard University Scores Big at 2019 NAFSA: Association of International Educators Conference, Wins $5K and Two Awards

Jimmy August

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

3 Shares
Share1
Tweet1
Share
Pin1